The In-Vitro Toxicology Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The In-Vitro Toxicology Testing Market:
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

According to The Business Research Company’s In-Vitro Toxicology Testing Global Market Report 2024, The in-vitro toxicology testing market size has grown rapidly in recent years. It will grow from $10.31 billion in 2023 to $11.46 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to regulatory requirements, ethical concerns and animal welfare, cost and time efficiency, globalization of the pharmaceutical industry, drug discovery and development demands, public awareness of environmental toxins..

The in-vitro toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $17.13 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to focus on personalized medicine, demand for predictive toxicology models, expansion of environmental testing, oncology drug development challenges, focus on endocrine disruptor screening, shift towards multi-organ chips.. Major trends in the forecast period include advancements in 3d cell culture technologies, integration of high-throughput screening, focus on organ-on-a-chip technologies, application in chemical safety assessment, use of human-derived cell lines, incorporation of omics technologies, educational initiatives and training programs..

Growing healthcare expenditure is expected to propel the in-vitro toxicology testing market going forward. Health expenditure is the amount of money spent by citizens and the government out of total income on hospitals, home health services, prescription pharmaceuticals, nursing facilities, and personal healthcare. Health expenditure is increasing in the world due to the rising prevalence of disease which utilizes in-vitro toxicology testing. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, it was estimated that between 2021 and 2030, national health spending is going to rise by an average of 5.1% every year, reaching almost $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the growing healthcare expenditure is driving the in-vitro toxicology testing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=7987&type=smp


The in-vitro toxicology testing market covered in this report is segmented –

1) By Product and Service: Consumables, Assays, Equipment, Software, Services
2) By Method: Cellular Assays, Biochemical Assays, In Silico Models, Ex Vivo Models
3) By Technology: Cell Culture Technologies, High-throughput Technologies, Toxicogenomics
4) By Applications: Neurotoxicity, Dermal toxicity, Cytotoxicity, Other Applications
5) By Industry: Pharmaceuticals and Biopharmaceuticals, Cosmetic and Household Products, Food, Chemicals

The development of innovative cell culture systems is a key trend gaining popularity in the in-vitro toxicology market. Major companies operating in the in-vitro toxicology testing market are focused on developing new technological solutions to strengthen their position. For instance, in August 2021, Amerigo Scientific, a US-based company operating in in-vitro toxicology testing launched 3D cell culture for scientific uses. This innovative vitro 3D cell culture technology offers a solution for precision medicine approaches that could host human and animal cells, making it a concrete solution for replacing and reducing small animal studies with both ethical and economic impacts in drug development.

Major Players:

Thermo Fisher Scientific Inc.
Merck KGaA
Laboratory Corporation of America Holdings (LabCorp)
Gentronix Limited
Bio-Rad Laboratories Inc.

The in-vitro toxicology testing market report table of contents includes:


1. Executive Summary
2. In-Vitro Toxicology Testing Market Characteristics
3. In-Vitro Toxicology Testing Market Trends And Strategies
4. In-Vitro Toxicology Testing Market - Macro Economic Scenario
5. Global In-Vitro Toxicology Testing Market Size and Growth

.

.

.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Related Reports:

https://goodprnews.com/disposable-medical-device-sensors-market-size/
https://goodprnews.com/dna-microarray-market-size/
https://goodprnews.com/docking-station-market-report/
https://topprnews.com/disposable-medical-device-sensors-market-size-and-share/
https://topprnews.com/dna-gene-chip-market-growth-drivers/
https://topprnews.com/docking-station-market-analysis

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model